Fabiano, Nicholas, Wong, Stanley, Gupta, Arnav, Tran, Jason, Bhambra, Nishaant, Min, Kevin K., Dragioti, Elena, Barbui, Corrado, Fiedorowicz, Jess G., Gosling, Corentin J., Cortese, Samuele, Gandhi, Jasmine, Saraf, Gayatri, Shorr, Risa, Vigod, Simone N., Frey, Benicio N., Delorme, Richard and Solmi, Marco (2024) Safety of psychotropic medications in pregnancy: an umbrella review. JAMA Network Open, 30, 327-335. (doi:10.1038/s41380-024-02697-0).
Abstract
Weighing risks and benefits of the use of psychotropic medications during pregnancy remains a challenge worldwide. We systematically assessed the strength of associations between psychotropic medication use in pregnant people with mental disorders and various adverse health outcomes in both pregnant people and foetuses. Systematic reviews with meta-analyses of observational studies investigating the association between exposure to psychotropic medication in pregnancy and any adverse health outcomes were included. Credibility was graded into convincing, highly suggestive, suggestive, weak or not significant. Quality of the meta-analyses and of individual studies were assessed with A Measurement Tool to Assess Systematic Reviews 2 (AMSTAR 2) the Newcastle-Ottawa Scale (NOS) respectively. We considered 21 meta-analyses encompassing 17,290,755 participants (AMSTAR 2 high=1, low=12, or critically low=8). Evidence was suggestive for: (1) preterm birth in pregnant people with either any mental disorder (equivalent odds ratio 1.62 (95% confidence interval 1.24-2.12) or depression (1.65 [1.34-2.02]) receiving antidepressants during any trimester of pregnancy; (2) small for gestational age for pregnant people with depression receiving a SSRI during any trimester of pregnancy (1.50 [1.19-1.90]); and (3) major congenital malformation (1.24 [1.09-1.40]) or cardiac malformations (1.28 [1.11-1.47]) in babies for pregnant people with depression or anxiety receiving paroxetine during first trimester of pregnancy. This umbrella review found no convincing or highly suggestive level of evidence of adverse health outcomes associated with psychotropic medication use in pregnant people with mental disorders.
More information
Identifiers
Catalogue record
Export record
Altmetrics
Contributors
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.